Article
The New Normal: How the Supply Chain has Been Impacted by COVID-19
Summary: Supply chains have come under intense pressure, and companies have had to adapt to this “new normal” to avoid delays. During this Q&A, Catalent discusses....
View Now
Webinars
Women in BioPharma Awards 2021
Summary: Join us as we honor a group of 20 extraordinary women who are making lasting impacts in the drug development field.
View Now
Webinars
Strategies to Accelerate the Path to Clinic for Next-Generation Antibodies
Summary: Experts discuss formulation development and purification strategies to increase throughput, reduce operating costs and decrease...
View Now
Webinars
Exploring New and Improved Analytical Methods for Traditional and Unique Modalities
Summary: During this presentation, experts will discuss the latest challenges in biophysical characterization and will present solutions to overcome these challenges.
View Now
Webinars
Endpoints 11 – BioPharma’s Most Promising Startups in 2021
Summary: This will be Endpoints’ 2021 look at 11 of the most important up-and-coming private biotechs in the business, independently selected by company founder and editor John Carroll.
View Now
Webinars
Biologics Analytical Methods: Trends and Strategies to Accelerate Biologics Development
Summary: This webinar summarizes the current bioanalytical landscape and its challenges, and discusses strategies to overcome them.
View Now
Webinars
The Post-COVID Pipeline Takes Shape: New Vaccines and Drugs During the mRNA Revolution
Summary: In this webinar, leaders in the field discuss new vaccines and drugs that have resulted from COVID and key learnings to prepare for the next pandemic.
View Now
Webinars
ASCO Explained: Expert Predictions for the World’s Biggest Cancer Meeting
Summary: This roundtable discussion offers a closer look at oncology's hottest fields, including CAR-T and precision medicine, 2021's biggest research trends and the data they're most looking forward to seeing.
View Now
Webinars
Harnessing mRNA as a Readout to Develop Robust BioPotency Assays
Summary: Catalent has developed a relative potency bioassay using real-time quantitative reverse transcription (RT-qPCR) in a duplex format to assess relative transcription activity in cells treated with ligands or transgenic vectors.
View Now
Webinars
Pharma Predictions for 2021
Summary: Catalent CEO John Chiminski to talks about the year ahead, offering projections for what 2021 holds in store for the biopharma industry.
View Now